Global Vaccine Market, By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Others), Type (Monovalent Vaccines, Multivalent Vaccines), Indication (Pneumococcal Disease, Influenza, Meningococcal Disease, Polio, Rotavirus, Hepatitis, Dengue, Herpes Zoster, Others), Route of Administration (Oral, Parenteral), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2029
Market Analysis and Insights
In recent years, the vaccine market is anticipated to grow rapidly during the forecast period of 2022-2029 due to the emergence of the COVID-19 pandemic. Vaccine technology has advanced dramatically in the recent decade, significantly altering the future of vaccine development. Many improvements in vaccine development programmes have been spurred by the introduction of genetic engineering, resulting in new products.
A vaccine allows a person to be exposed to a pathogen in a controlled manner. Governments all across the world have been concentrating their efforts on reducing global disease burdens, particularly for vaccine-preventable diseases. Vaccination has also been regarded as the first line of defense in the event of an endemic or pandemic outbreak, which could result in healthcare issues.
Data Bridge Market Research analyses that the vaccine market will grow at a CAGR of 9.22% during the forecast period of 2022 to 2029.
Vaccine Market Dynamics
- Prevalence of infectious diseases will increase market demand.
The rise in the prevalence rate of emerging and re-emerging infectious diseases act as a major driver that will result in the expansion of the growth rate of the treatment market.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of vaccine market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness about new treatment options, and growing government funding for vaccine development are the factors that will expand the vaccine market. Other factors such as growing geriatric population and rising focus on immunization development will positively impact the vaccine market's growth rate. Additionally, high disposable income, continuously changing lifestyle and high target affinity and specificity will result in the expansion of the vaccine market.
- Rise in the investment for R&D by public and private organizations
Moreover, the rise in the vaccine research and development activities and increasing use of adjuvants in vaccines will boost new opportunities for the market's growth rate.
Also, continuous economic development and surging focus on therapeutic vaccine will escalate the growth rate of vaccine market in the future.
However, high cost associated with the vaccine development and lack of infrastructure in low-income countries will impede the growth rate of vaccine market. Additionally, low purchasing power in under-developed countries will hinder the vaccine market growth. The lack of awareness and inequitable access to vaccines will further challenge the market in the forecast period mentioned above.
This vaccine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Vaccine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Vaccine Market
Due to the COVID-19 pandemic, the majority of healthcare, pharmaceutical, and biotechnology companies have focused on diagnostic kits, safety wearables, and novel coronavirus treatment vaccines and medications. The majority of the leading pharmaceutical companies are concentrating their efforts on developing a novel coronavirus vaccine. Furthermore, medical experts are involved in COVID-19-related services. As a result, other areas of healthcare are being neglected. Furthermore, pharmaceutical companies are emphasising COVID-19-related diagnostics, therapies, health technologies, and vaccinations and evaluating the efficacy of existing treatments. All of these factors are positively impacting the global vaccines market and will impact in the future.
- In August 2021, GlaxoSmithKline plc had announced their submission of Biologics License Application (BLA) to United States Food and Drug Administration (USFDA) for their investigational vaccine PRIORIX. The vaccine was first registered in Germany and recently licensed in over 100 countries globally.
- In June 2020, Mitsubishi Tanabe Pharma Corporation had announced collaboration of their affiliate company Medicago Inc. and GlaxoSmithKline plc. They formed a collaboration to develop a plant-based virus-like particle (VLP) vaccine for COVID-19.
Vaccine Market Scope
The vaccine market is segmented on the basis of technology, type, indication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
On the basis of technology, the vaccine market is segmented into conjugate vaccines, inactivated and subunit vaccines live attenuated vaccines and others.
- Monovalent Vaccines
- Multivalent Vaccines
The type segment for vaccine market includes monovalent vaccines, multivalent vaccines.
- Pneumococcal Disease
- Meningococcal Disease
- Herpes Zoster
On the basis of indication, vaccine market is segmented into pneumococcal disease, influenza, meningococcal disease, polio, rotavirus, hepatitis, dengue, herpes zoster and others.
Route of Administration
On the basis of route of administration, the vaccine market is segmented into oral, parenteral and others.
On the basis of end-users, the vaccine market is segmented into clinic, hospital and others.
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
The vaccine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Vaccine Market Regional Analysis/Insights
The vaccine market is analysed and market size insights and trends are provided by country, technology, type, indication, route of administration, end-users and distribution channel as referenced above.
The countries covered in the vaccine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the vaccine market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing patient pool, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Vaccine Market Share Analysis
The vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine market.
Some of the major players operating in the vaccine market are Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, DAIICHI SANKYO COMPANY, LIMITED, Mitsubishi Tanabe Pharma Corporation, Sun Pharmaceutical Industries Ltd., Sanofi, CSL Limited, Panacea Biotec, EMERGENT, Novavax, Inc., INOVIO Pharmaceuticals, Bavarian Nordic, Sinovac Biotech Ltd., Bharat Biotech, Biotec, Serum Institute of India Pvt. Ltd., AstraZeneca, Johnson & Johnson Private Limited, and Indian Immunologicals Ltd., among others.
Research Methodology : Global Vaccine Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available : Global Vaccine Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.